Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study.
about
Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on TrabectedinA Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: an NRG Oncology/Gynecologic Oncology Group StudyFixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II studyA phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: a gynecologic oncology group study.Locally-advanced unresected uterine leiomyosarcoma with triple-modality treatment combining radiotherapy, chemotherapy and hyperthermia: A case report.Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome.Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line.New drug developments for patients with metastatic soft tissue sarcoma.Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015).A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma.A review of treatment of uterine leiomyosarcomas.Optimal management of uterine leiomyosarcoma.A novel method to identify differential pathways in uterine leiomyomata based on network strategy.Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma.Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan.
P2860
Q28087771-4FFEABCA-6471-4B2D-AF96-C071BF89E8A3Q30370631-CC816E4B-4C51-47D0-8F35-6C28076E73D8Q30439459-730C17BB-3700-4873-9BB9-3F35472F3B38Q33379886-BA173FBE-01BC-47D0-9D0F-538E537DDB10Q33386535-7647A0CF-7308-4EAB-806E-04C52C18C9C4Q33397625-59E55C74-1D85-4DA7-BE19-FA93080B5DB3Q33844215-5B4479A1-BE1F-4B28-B048-5E8EC96E1BD3Q35152557-5F391974-2BDF-49AD-9717-F76F08264285Q36117059-4D33173F-5760-4415-BEB5-37D45FB3C1BDQ36157324-44931D72-2D4E-46B4-B574-CF3348EE0B24Q36295510-38594445-176E-4D79-8D64-A803CCA358A1Q37296303-9B98802D-49F6-4844-AD7B-A16C8A48EE70Q38153648-B8DDAE5E-98C3-4F0D-9539-9805FCA78ABDQ43173702-31ABAB5B-DF16-48FE-9491-60FD5E1683A2Q46002275-6B7089D0-1108-488C-A496-CAB8C7E2C1E5Q53367383-6F2C4CEA-B7BD-41CC-9D4C-E7667D5BAF8AQ54711421-9FA881E0-D00E-4DAA-8164-40ECA9CE8DA5
P2860
Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Evaluation of paclitaxel in pr ...... ecologic oncology group study.
@ast
Evaluation of paclitaxel in pr ...... ecologic oncology group study.
@en
type
label
Evaluation of paclitaxel in pr ...... ecologic oncology group study.
@ast
Evaluation of paclitaxel in pr ...... ecologic oncology group study.
@en
prefLabel
Evaluation of paclitaxel in pr ...... ecologic oncology group study.
@ast
Evaluation of paclitaxel in pr ...... ecologic oncology group study.
@en
P2093
P1433
P1476
Evaluation of paclitaxel in pr ...... ecologic oncology group study.
@en
P2093
Donald G Gallup
Gynecologic Oncology Group Study
John A Blessing
Mark A Morgan
Willie Andersen
P356
10.1016/S0090-8258(02)00136-1
P407
P577
2003-04-01T00:00:00Z